Decapeptyl Depot 3.75mg

Decapeptyl Depot

Active Ingredient:
Triptorelin Acetate Injection

Buy Decapeptyl Depot Triptorelin Acetate Injection

Decapeptyl Depot (Triptorelin Acetate Injection 3.75mg) is a prescription injectable used in hormone therapy. This depot formulation provides sustained release for broad therapeutic applications. Ideal for patients requiring long-acting hormonal regulation. Short-acting versions may be available separately.

Strength

3.75mg

Pack Size

1s

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Triptorelin Acetate Injection 3.75mg is commonly used in hormone-dependent conditions such as prostate cancer, endometriosis, and precocious puberty. It works by regulating gonadotropin-releasing hormone (GnRH) to manage hormone levels. This medication is also used in assisted reproductive therapy protocols. Patients often ask what is triptorelin acetate injection used for in fertility treatments.

Side Effects

  • This injectable formulation provides a gradual release of triptorelin acetate over time, supporting consistent hormone modulation. Users may experience temporary changes in energy or mood as the body adjusts to altered hormone levels. The effects are intended to support therapeutic goals rather than produce immediate symptomatic relief.

Precautions & Warnings

  • Store this medication at controlled room temperature, away from moisture and direct light. Keep out of reach of children and pets. Do not use if the solution is discolored or contains particles. Always follow healthcare provider instructions for administration and disposal. Report any unusual reactions promptly.

Avoid Interactions

  • Triptorelin acetate may interact with other hormone therapies or medications affecting pituitary function. Caution is advised when combining with drugs that alter electrolyte balance or cardiovascular medications. Alcohol and certain supplements may influence effectiveness or side effects. Always disclose all medications to your healthcare provider before starting triptorelin acetate.

Frequently Asked Questions

It is used in hormone therapy for conditions like prostate cancer, endometriosis, and precocious puberty.

The 3.75mg depot formulation is designed for sustained release over a set period, typically one month.

This medication requires a prescription and should only be obtained through licensed pharmacies.

Users may experience temporary changes in mood, energy, or hot flashes as the body adjusts.

This medication is not recommended for use during pregnancy unless specifically directed by a healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.